MIT Koch Institute for Integrative Cancer Research
Research ServicesMassachusetts, United States201-500 Employees
The Koch Institute for Integrative Cancer Research at MIT functions as a National Cancer Institute-designated basic cancer research center and a central hub for cancer research on the MIT campus. It brings together scientists from biology, chemistry, engineering, computer science, and clinical disciplines in a purpose-built facility to pursue cancer research from multiple angles. Researchers there focus on five priority areas: nanotechnology-based cancer therapeutics, detection and monitoring, metastasis, precision cancer medicine, and cancer immunology and immunotherapy. The institute engages with external clinical centers and industry partners to advance understanding, detection, and treatment of cancer. Based in Cambridge, Massachusetts, the institute operates within MIT’s research ecosystem to generate new insights, tools, and technologies aimed at improving detection, treatment, and prevention of cancer. As a center for interdisciplinary collaboration, it partners with external organizations such as NCI-designated clinical cancer centers and biotech/pharma entities to translate research into applied cancer care.